Continuing Education Activity

Claustrophobia is the fear of enclosed spaces. About 12.5% of the population have this fear, with the majority of them being women. Claustrophobia is a specific phobia where one fears closed spaces (claustro means closed). Examples of closed spaces include engine rooms, small or locked rooms, cellars, tunnels, elevators, magnetic resonance imaging machines, subway trains, crowded places, etc. Claustrophobic people are not frightened of enclosed spaces per se but of what could happen in the enclosed space. This activity reviews the evaluation and management of claustrophobia and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.

Objectives:

• Identify the etiology of claustrophobia.
• Outline the typical presentation of a patient with claustrophobia.
• Summarize the management options available for claustrophobia.
• Review interprofessional team strategies for improving care coordination and communication to manage claustrophobia and improve outcomes.

Introduction

A phobia is a fear which causes significant impairment in a person's ability to live everyday life. An example of life impairment is avoiding the feared object or scenario.[1] According to the Diagnostic and Statistical Manual of Mental Disorders 5th ed (DSM-5), there are many categories of anxiety disorders. These include separation anxiety disorder, social anxiety disorder, panic disorder, generalized anxiety disorder, selective mutism, and specific phobias. The specific phobias can be further subdivided into animal, natural/environmental, situational, and blood injection injury types.[2] Specific phobias are an extreme fear of certain activities, persons, objects, or situations.[3]

Claustrophobia is a specific phobia where one fears closed spaces (claustro means closed). Examples of closed spaces are engine rooms, small or locked rooms, cellars, tunnels, elevators, magnetic resonance imaging machines, subway trains, or crowded places.[4] Those with specific phobias generally will report avoidance behaviors regarding the particular object or situation that triggers their fear. The fear can be expressed as a danger of harm, disgust, or experience of physical symptoms in a phobic scenario.[5] It can be unpleasant and distressful; however, most patients find ways to cope by avoiding small or enclosed places. People who react to one of the trigger situations potentially respond to them all. Fear of being trapped, for instance, waiting in a long queue or sitting in a dentist's chair, is also regarded as a sign of claustrophobia.

Claustrophobic people are not frightened of enclosed spaces per se but of what could happen in the enclosed space. As agoraphobia is increasingly being recognized as a fear of what might unfold in a public place, such as having a panic attack, claustrophobia can also be regarded in this manner—a subjective sense of being trapped features in the accounts of most claustrophobic people. Most closed places entail some level of entrapment along with a restriction of movement. Animals certainly, and people potentially, are vulnerable "in situations of confined space"; experimental neuroses are easily induced when an animal is put in a confined environment.[6] Fear of suffocation concerns claustrophobic people. This extraordinarily intense and expected component of claustrophobia is interpreted as a grave threat by claustrophobic people. Many claustrophobic people experience a fear of suffocation when in an enclosed space which is closely associated with the sensation of shortness of breath.

Etiology

Social anxiety disorder is a DSM-V psychiatric condition characterized by an intense fear of social situations and scrutiny—patients who have claustrophobia display a great fear and anxiety of closed spaces. The belief with a social anxiety disorder is that the frontal regions of the brain cannot downregulate amygdalar hyper-activation. The same disruptions in the amygdala-frontal network in social anxiety disorder are attributable to claustrophobia.[7] A meta-analysis of functional brain imaging in specific phobias showed the activated regions of the brain to phobic stimuli were globus pallidus, amygdala, and left insula.[8]

There are two phenomena associated with innate pathological fear, fear sensitization and failure of fear habituation. The amygdala has a decreased threshold activity and decreased potentiation of activity in fear sensitization. Research suggests a dysfunction in the learning-independent fear circuit, which drives defensive behavior without prior learning, in nonexperiential phobias. Habituation is the reduced emotional reaction of a person to repeated stimuli. In fear habituation, the amygdala has decreased habituation.[3] A single gene defect in the human GPM6A gene is a suspected genetic risk for claustrophobia. The GPM6A gene, expressed in the amygdala and throughout the central nervous system, encodes a stress-regulated neuronal protein found on chromosome 4q32-q34, associated with panic disorder.[9]

Epidemiology

Claustrophobia has a lifetime and 12-month prevalence of 7.7% to 12.5%.[10] There is a higher prevalence of specific phobias in women.[11] Studies conclude that there is a 1 in 10 prevalence of anxiety disorder among people before age 16.[2] A 2007 European study reviewed various studies from different institutions and observed reported rates of claustrophobia among people undergoing magnetic resonance image ranging between 1% and 15%, with an average of 2.3% of patients needing sedation or being unable to be imaged because of claustrophobia.[12]

History and Physical

Patients with specific phobias report various physical and emotional symptoms. Based on these symptoms, practitioners utilize screening tools to diagnose patients with claustrophobia. Physical symptoms include, but are not limited to, difficulty breathing, trembling, sweating, tachycardia, dry mouth, and chest pain. Emotional symptoms include but are not limited to, overwhelming anxiety or fear, fear of losing control, an intense need to leave the situation, and understanding the fear as irrational but an inability to overcome it.[13]  People with claustrophobia tend to feel the fear of what might happen in a confined space which leads to the sense of oxygen not being adequate. Thinking about it or being confined may trigger a fear of being unable to breathe adequately, running out of oxygen, and being restricted. When anxiety levels exceed, the person may begin to experience:

• Sweating and chills
• Increased heart rate and high blood pressure
• Dizziness and lightheadedness
• Dry mouth
• Hyperventilation
• Hot flashes
• Nausea
• Headache
• Numbness
• A choking sensation
• Chest tightness/pain and difficulty breathing
• An urge to urinate
• Confusion

Not all people with claustrophobia will present with all these features, as the presentation can be variable.

Evaluation

Claustrophobia evaluation starts with a patient who presents with the symptoms of fear. It needs to be determined if the fear represents a phobia, normal fear, a general medical condition, or an anxiety disorder. Questions in the initial history taking part in the assessment that assesses how the fear impacts the person's development, daily life, and family dynamics are vital to distinguishing anxiety and phobias. For children, sample questions are: How do the child's parents respond to their fear? Can the child or parent recall the exact trigger of the anxiety? Is there any interruption in the child's daily schedule more than 3 times a day?[14] Questionnaires are options to evaluate claustrophobia. The Spielberger psychology questionnaire consists of 20 items; each scored from 20 to 80, which measures apparent anxiety.[15] There are three commonly used scales to assess symptoms of anxiety and fear in the younger population: The revised Children's Manifest Scale, the Fear Survey Schedule for Children-Revised, and the State-Trait Anxiety Inventory for Children.[2]

Treatment / Management

The mainstay of management for claustrophobia is cognitive behavioral therapy, in which the patient can discuss negative and distorted beliefs.[16] Interoceptive exposure is a form of treatment where the patient gets exposed to the physical sensation of anxiety in a controlled environment.[17] A study reported that interoceptive exposure delivered alone was more helpful to people whose feared outcomes about physical arousal were completely intrinsic and less useful for those whose feared outcomes involved extrinsic components.[18]

Utilizing virtual reality (VR) technology in a stimulating computer-generated atmosphere is one option for treating claustrophobia. Studies have indicated the efficacy of VR tools (apps) in educating patients about MRI and simulating the experience of actually being scanned.[19] The claustrophobia game is an example of both an elevator and magnetic resonance imaging device scenario for closed spaces.[15] The many treatment options for pathological fear have only resulted in about 40% of patients having long-term benefits; most will fail to have complete remission.[3]

Medications may also be used in the management of this phobia. Options include benzodiazepines, selective serotonin reuptake inhibitors, and other investigational drugs (cycloserine, hydrocortisone, quetiapine).[20] Benzodiazepines are the most commonly used pharmacological option for patients with specific phobias who infrequently encounter unavoidable phobic stimuli.[21] There have been studies on the effectiveness of both escitalopram and paroxetine.[22] Hydrocortisone is a glucocorticoid; endogenous glucocorticoids' mechanism of action is unknown, but what is known is that they are released when a patient is in a fearful situation. A study showed that patients undergoing cognitive-behavioral therapy have an augmented effect with 10 mg of oral hydrocortisone.[23]

Differential Diagnosis

A community survey of 9282 adults residing in the United States showed that the presence of one specific phobia is associated with the prevalence of post-traumatic stress disorder, social phobia, bipolar disorder, generalized anxiety disorder, alcohol dependence, separation anxiety disorder, and major depressive disorder.[24] Post-traumatic stress disorder is a common disorder that merits consideration in the differential. The main distinguishing reason is the presence of a traumatic event causing PTSD. A specific phobia is not always preceded by a traumatic event (experiential-specific phobia vs nonexperiential-specific phobia).[3]

Prognosis

Patients with claustrophobia commonly have a chronic course of their anxiety disorder, increasing the risk of other psychopathology.[2] Studies have shown that adolescents with increased phobias had an earlier onset of the disorder. From the same studies, patients with situational and blood-injection-injury-specific phobias were the most strongly associated with indices of impairment and severity.[11] Natural environment phobias correlated with more social problems and increased symptoms of depression and anxiety than animal phobias.[25]

Complications

There is an 83% likelihood of uncovering multiple specific phobias once diagnosed with a particular phobia during a patient's life.[11] Claustrophobia alone generally does not lead to thoughts of self-harm, culminating in suicide. In rare cases, claustrophobia, in combination with depression, anxiety, or any other form of mental health problem, can cause suicidal ideation. In patients needing magnetic resonance image scans for diagnosis or management, claustrophobia can portend a significant risk as some patients might not be able to go through the procedure despite extra help. In some cases, claustrophobia can restrict the patient's social life, as using elevators, changing rooms, and subways might bring on an episode of panic, leading to a sudden decline.

Consultations

In managing people with claustrophobia, the following can be helpful:

• Psychologists
• Psychiatrists
• Counselors

Deterrence and Patient Education

Patients must be provided with information on the symptoms and criteria necessary for claustrophobia. They will be better able to seek help and address their anxiety about enclosed environments once they can identify the origin of their anxiety. People should be advised on self-help techniques to manage their stress/anxiety during an episode. It is advisable to avoid the triggers as much as possible to maintain a healthy life. In addition, they should be informed about the treatment options available so they can make an informed choice.

Enhancing Healthcare Team Outcomes

There must be an interprofessional team approach to patients with claustrophobia and other specific phobias. The nursing staff, clinicians, and ancillary staff members aim to decrease the patient's anxiety, especially in anxiety-provoking scenarios, such as a magnetic resonance image procedure. Clinicians need to determine which part of the magnetic resonance image procedure is the most anxiety-provoking for the patient, acknowledge their concerns, and address their specific phobia. However, it is essential to avoid undermining the patient's concerns and implying that they can choose to stop the fear they experience at will. The patient should be counseled on how they can have the most significant control level during the procedure to have comfort, such as allowing a family member into the room with them during the procedure (when clinically appropriate).[26] The management of anxiety disorders requires an interprofessional team that includes physicians, nurses, other technicians (eg, radiation techs), and, where appropriate, pharmacists to communicate and collaborate in treating the condition. They also help the patient through anxiety-producing procedures (such as a magnetic resonance image) to achieve optimal patient outcomes. 

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Schowalter JE. Fears and phobias. Pediatr Rev. 1994 Oct;15(10):384-8. [PubMed: 7997438]

2.

Muris P, Simon E, Lijphart H, Bos A, Hale W, Schmeitz K., International Child and Adolescent Anxiety Assessment Expert Group (ICAAAEG). The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents. Child Psychiatry Hum Dev. 2017 Feb;48(1):1-17. [PMC free article: PMC5243875] [PubMed: 27179521]

3.

Garcia R. Neurobiology of fear and specific phobias. Learn Mem. 2017 Sep;24(9):462-471. [PMC free article: PMC5580526] [PubMed: 28814472]

4.

Yeh SC, Li YY, Zhou C, Chiu PH, Chen JW. Effects of Virtual Reality and Augmented Reality on Induced Anxiety. IEEE Trans Neural Syst Rehabil Eng. 2018 Jul;26(7):1345-1352. [PubMed: 29985143]

5.

LeBeau RT, Glenn D, Liao B, Wittchen HU, Beesdo-Baum K, Ollendick T, Craske MG. Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Depress Anxiety. 2010 Feb;27(2):148-67. [PubMed: 20099272]

6.

Wolpe J. Psychotherapy by reciprocal inhibition. Cond Reflex. 1968 Oct-Dec;3(4):234-40. [PubMed: 5712667]

7.

Minkova L, Sladky R, Kranz GS, Woletz M, Geissberger N, Kraus C, Lanzenberger R, Windischberger C. Task-dependent modulation of amygdala connectivity in social anxiety disorder. Psychiatry Res Neuroimaging. 2017 Apr 30;262:39-46. [PubMed: 28226306]

8.

Ipser JC, Singh L, Stein DJ. Meta-analysis of functional brain imaging in specific phobia. Psychiatry Clin Neurosci. 2013 Jul;67(5):311-22. [PubMed: 23711114]

9.

El-Kordi A, Kästner A, Grube S, Klugmann M, Begemann M, Sperling S, Hammerschmidt K, Hammer C, Stepniak B, Patzig J, de Monasterio-Schrader P, Strenzke N, Flügge G, Werner HB, Pawlak R, Nave KA, Ehrenreich H. A single gene defect causing claustrophobia. Transl Psychiatry. 2013 Apr 30;3(4):e254. [PMC free article: PMC3641414] [PubMed: 23632458]

10.

Wardenaar KJ, Lim CCW, Al-Hamzawi AO, Alonso J, Andrade LH, Benjet C, Bunting B, de Girolamo G, Demyttenaere K, Florescu SE, Gureje O, Hisateru T, Hu C, Huang Y, Karam E, Kiejna A, Lepine JP, Navarro-Mateu F, Oakley Browne M, Piazza M, Posada-Villa J, Ten Have ML, Torres Y, Xavier M, Zarkov Z, Kessler RC, Scott KM, de Jonge P. The cross-national epidemiology of specific phobia in the World Mental Health Surveys. Psychol Med. 2017 Jul;47(10):1744-1760. [PMC free article: PMC5674525] [PubMed: 28222820]

11.

Burstein M, Georgiades K, He JP, Schmitz A, Feig E, Khazanov GK, Merikangas K. Specific phobia among U.S. adolescents: phenomenology and typology. Depress Anxiety. 2012 Dec;29(12):1072-82. [PMC free article: PMC3955257] [PubMed: 23108894]

12.

Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55,000 patients. J Magn Reson Imaging. 2007 Nov;26(5):1322-7. [PubMed: 17969166]

13.

Murphy JM, Leighton AH. Anxiety: its role in the history of psychiatric epidemiology. Psychol Med. 2009 Jul;39(7):1055-64. [PMC free article: PMC3840421] [PubMed: 18940025]

14.

Connolly SD, Bernstein GA., Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):267-83. [PubMed: 17242630]

15.

Rahani VK, Vard A, Najafi M. Claustrophobia Game: Design and Development of a New Virtual Reality Game for Treatment of Claustrophobia. J Med Signals Sens. 2018 Oct-Dec;8(4):231-237. [PMC free article: PMC6293643] [PubMed: 30603615]

16.

Thorpe S, Salkovskis PM, Dittner A. Claustrophobia in MRI: the role of cognitions. Magn Reson Imaging. 2008 Oct;26(8):1081-8. [PubMed: 18524527]

17.

Booth R, Rachman S. The reduction of claustrophobia--I. Behav Res Ther. 1992 May;30(3):207-21. [PubMed: 1586358]

18.

Boettcher H, Barlow DH. The unique and conditional effects of interoceptive exposure in the treatment of anxiety: A functional analysis. Behav Res Ther. 2019 Jun;117:65-78. [PubMed: 30579624]

19.

Brown RKJ, Petty S, O'Malley S, Stojanovska J, Davenport MS, Kazerooni EA, Fessahazion D. Virtual Reality Tool Simulates MRI Experience. Tomography. 2018 Sep;4(3):95-98. [PMC free article: PMC6173786] [PubMed: 30320208]

20.

Choy Y, Fyer AJ, Lipsitz JD. Treatment of specific phobia in adults. Clin Psychol Rev. 2007 Apr;27(3):266-86. [PubMed: 17112646]

21.

Sozio SJ, Bian Y, Marshall SJ, Rivera-Núñez Z, Bacile S, Roychowdhury S, Youmans DC. Determining the efficacy of low-dose oral benzodiazepine administration and use of wide-bore magnet in assisting claustrophobic patients to undergo MRI brain examination. Clin Imaging. 2021 Nov;79:289-295. [PubMed: 34198113]

22.

Alamy S, Wei Zhang, Varia I, Davidson JR, Connor KM. Escitalopram in specific phobia: results of a placebo-controlled pilot trial. J Psychopharmacol. 2008 Mar;22(2):157-61. [PubMed: 18208904]

23.

de Quervain DJ, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J, Wilhelm FH. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6621-5. [PMC free article: PMC3081033] [PubMed: 21444799]

24.

Stinson FS, Dawson DA, Patricia Chou S, Smith S, Goldstein RB, June Ruan W, Grant BF. The epidemiology of DSM-IV specific phobia in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2007 Jul;37(7):1047-59. [PubMed: 17335637]

25.

Ollendick TH, Raishevich N, Davis TE, Sirbu C, Ost LG. Specific phobia in youth: phenomenology and psychological characteristics. Behav Ther. 2010 Mar;41(1):133-41. [PMC free article: PMC3380611] [PubMed: 20171334]

26.

Weinreb JC, Maravilla KR, Peshock R, Payne J. Magnetic resonance imaging: improving patient tolerance and safety. AJR Am J Roentgenol. 1984 Dec;143(6):1285-7. [PubMed: 6333798]

Disclosure: Christy Vadakkan declares no relevant financial relationships with ineligible companies.

Disclosure: Waquar Siddiqui declares no relevant financial relationships with ineligible companies.